At a glance

ClinicalIndex Comparison Record

N/ACompleted· 106 enrolled

Drug / intervention

Oxytocin spray +1 moredrug

Likely dose

Oxytocin spray 24 IUfrom record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01823146

NCT01823146N/ACompleted

Compare CT.gov

Oxytocin and Aging: Neuro-Behavioral Effects on Social Cognition and Prosocial Behavior

University of Florida·interventional·Posted Apr 4, 2013·Updated Aug 25, 2016

In Brief

A clinical study evaluating Oxytocin spray and Placebo spray for Aging. Completed, enrolled 106 participants across 1 site.

Detailed Summary

This study will investigate the extent to which intranasal oxytocin affects changes in social decision making and evaluations of others. Oxytocin is a hormone that naturally occurs in the body and the brain and has been shown to be relevant for many behaviors, particularly in social situations. Research on the effects of oxytocin in aging is very scarce; therefore, the purpose of this research project is to determine the effects of oxytocin on socioemotional aging.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsAging

CountriesUnited States

Collaborators--

Timeline

N/ACompletedFinished

20132014201520162017201820192020202120222023202420252026

First PostedApr 2013

Enrollment StartJul 2013

Primary CompletionSep 2014

TodayJul 2026

First PostedApr 4, 2013

Enrollment StartJul 1, 2013

Primary CompletionSep 1, 2014

TodayJul 2, 2026

Enrollment to primary: 1.2 yearsPosted 13.2 years ago

Interventions

Oxytocin spraydrug

single dose of 24 IU oxytocin, self-administered intranasally (IN)

Placebo spraydrug

single dose of 24 IU placebo (same solution as oxytocin spray but without oxytocin), self-administered intranasally (IN)